FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves a supplemental application for Rabeprazole sodium from Amneal Pharmaceuticals LLC (ANDA 204179).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Nsaid-associated Gastroduodenal Injury

Drugs mentioned

• Rabeprazole sodium (rabeprazole)

Snippet

SUPPL AP for RABEPRAZOLE SODIUM (RABEPRAZOLE)